Verve Therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. Founded ... by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2020, Verve was recognized as a "Best Places to Work" by the Boston Business Journal and one of the "Endpoints 11." Verve is headquartered in Cambridge, Massachusetts. read more